Author:
Kaplan Frederick S.,Shen Qi,Lounev Vitali,Seemann Petra,Groppe Jay,Katagiri Takenobu,Pignolo Robert J.,Shore Eileen M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference96 articles.
1. Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2005) Introduction. Clin Rev Bone Miner Metab 3(3–4):175–177
2. Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor JM, Kitterman JA (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183–188
3. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, Le Merrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossi-ficans progressiva. Nat Genet 38:525–527
4. Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A, Sando N, Zasloff M, Kaplan FS (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:215–219
5. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS (1994) Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 301:243–248
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献